Cite
Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
MLA
Na Xu, et al. “Correlation between Deletion of the CDKN2 Gene and Tyrosine Kinase Inhibitor Resistance in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.” Journal of Hematology & Oncology, vol. 9, Apr. 2016, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s13045-016-0270-5.
APA
Na Xu, Yu-ling Li, Xuan Li, Xuan Zhou, Rui Cao, Huan Li, Lin Li, Zi-yuan Lu, Ji-xian Huang, Zhi-ping Fan, Fen Huang, Hong-sheng Zhou, Song Zhang, Zhi Liu, Hong-qian Zhu, Qi-fa Li, & Xiao-li Liu. (2016). Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia. Journal of Hematology & Oncology, 9, 1–8. https://doi.org/10.1186/s13045-016-0270-5
Chicago
Na Xu, Yu-ling Li, Xuan Li, Xuan Zhou, Rui Cao, Huan Li, Lin Li, et al. 2016. “Correlation between Deletion of the CDKN2 Gene and Tyrosine Kinase Inhibitor Resistance in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.” Journal of Hematology & Oncology 9 (April): 1–8. doi:10.1186/s13045-016-0270-5.